Noticeably, a study using a small cohort of samples from pancreatic cancer reported a positive correlation between Dyn2 expression and malignancy although no comparison was made to clinical parameters such as outcome 31. The gene discussed is DNM2; the disease is familial pancreatic carcinoma.